Skip to main content

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-01-2009 | Beschouwing

Prikkelbaredarmsyndroom in de huisartsenpraktijk

Auteur: René Bijkerk

Gepubliceerd in: Huisarts en wetenschap | Uitgave 1/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

In deze beschouwing worden aanbevelingen gegeven voor de diagnostiek en behandeling van PDS-patiënten. Huisartsen kunnen PDS-patiënten op basis van de symptomen met zekerheid identificeren. Bij alarmsymptomen is aanvullend onderzoek geïndiceerd. De diagnose PDS wordt in de huisartsenpraktijk tevens bepaald door het ‘patiëntenprofiel’. De karakteristieken daarvan zijn: een frequent consultatiepatroon, een verhoogde prevalentie van somatische en psychiatrische comorbiditeit en een voorgeschiedenis met lichamelijk onverklaarde klachten. De huisarts zou de behandeling moeten starten met het onderzoeken van de perceptie en verwachtingen van de patiënt. De volgende stap is het geven van uitleg en geruststelling, waarbij de goedaardige achtergrond van het syndroom wordt uitgelegd. Leefstijlaanpassing is onderdeel van de behandeling. PDS-patiënten met functionele of psychiatrische comorbiditeit hebben mogelijk baat bij psychologische interventies of medicamenteuze behandeling.
Literatuur
1.
go back to reference Cayley WE. Irritable bowel syndrome. BMJ 2005;330:632. Cayley WE. Irritable bowel syndrome. BMJ 2005;330:632.
2.
go back to reference Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007;39:201-15. Ohman L, Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007;39:201-15.
3.
go back to reference Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology 1998;114:559-78. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology 1998;114:559-78.
4.
go back to reference Wilhelmsen I. Brain-gut axis as an example of the bio-psycho-social model. Gut 2000;47 Suppl 4:iv5-7. Wilhelmsen I. Brain-gut axis as an example of the bio-psycho-social model. Gut 2000;47 Suppl 4:iv5-7.
5.
go back to reference Kamm MA. The role of psychosocial factors in functional gut disease. Eur J Surg Suppl 1998;:37-40. Kamm MA. The role of psychosocial factors in functional gut disease. Eur J Surg Suppl 1998;:37-40.
6.
go back to reference Bijkerk CJ, De Wit NJ, Stalman WA, Knottnerus JA, Hoes AW, Muris JW. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 2003;17:363-8. Bijkerk CJ, De Wit NJ, Stalman WA, Knottnerus JA, Hoes AW, Muris JW. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 2003;17:363-8.
7.
go back to reference Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-7. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-7.
8.
go back to reference Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
9.
go back to reference Bijkerk CJ. Irritable bowel syndrome in primary care. Utrecht: University Medical Center Utrecht, 2008. Bijkerk CJ. Irritable bowel syndrome in primary care. Utrecht: University Medical Center Utrecht, 2008.
10.
go back to reference Rubin G, de Wit NJ, Meineche-Schmidt V, Seifert B, Hall N, Hungin P. The diagnosis of IBS in primary care: consensus development using nominal group technique. Fam Pract 2006;23:687-92. Rubin G, de Wit NJ, Meineche-Schmidt V, Seifert B, Hall N, Hungin P. The diagnosis of IBS in primary care: consensus development using nominal group technique. Fam Pract 2006;23:687-92.
11.
go back to reference Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51.
12.
go back to reference Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
13.
go back to reference Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, et al. Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:1667-75. Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, et al. Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:1667-75.
14.
go back to reference Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-203. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-203.
15.
go back to reference Van der Horst HE, Van Dulmen AM, Schellevis FG, Van Eijk JT, Fennis JF, Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997;41:669-74. Van der Horst HE, Van Dulmen AM, Schellevis FG, Van Eijk JT, Fennis JF, Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997;41:669-74.
16.
go back to reference Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51.
17.
go back to reference Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002;97:2290-9. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002;97:2290-9.
18.
go back to reference Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004;99:350-7. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004;99:350-7.
19.
go back to reference Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56.
20.
go back to reference Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000 ;47 Suppl 2:ii1-19. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000 ;47 Suppl 2:ii1-19.
21.
go back to reference De Wit NJ, Van der Wind D, Schellevis FG, Van der Horst HE. Epidemiology and clinical management of irritable bowel syndrome in primary care; one year results from a nationwide database. Gut Suppl III 56, A40, 2007. Ref Type: Abstract. De Wit NJ, Van der Wind D, Schellevis FG, Van der Horst HE. Epidemiology and clinical management of irritable bowel syndrome in primary care; one year results from a nationwide database. Gut Suppl III 56, A40, 2007. Ref Type: Abstract.
22.
go back to reference Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999;94:1279-82. Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999;94:1279-82.
23.
go back to reference Thompson WG. The treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2002;16:1395-406. Thompson WG. The treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2002;16:1395-406.
24.
go back to reference Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642-7. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642-7.
25.
go back to reference Oberndorff-Klein Woolthuis AH, Brummer RJ, De Wit NJ, Muris JW, Stockbrugger RW. Irritable bowel syndrome in general practice: an overview. Scand J Gastroenterol Suppl 2004;241:17-22. Oberndorff-Klein Woolthuis AH, Brummer RJ, De Wit NJ, Muris JW, Stockbrugger RW. Irritable bowel syndrome in general practice: an overview. Scand J Gastroenterol Suppl 2004;241:17-22.
26.
go back to reference Cardol M, Van Dijk L, De Jong JD, De Bakker DH, Westert GP. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Huisartsenzorg: wat doet de poortwachter? Utrecht/Bilthoven: NIVEL/RIVM, 2004. Cardol M, Van Dijk L, De Jong JD, De Bakker DH, Westert GP. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Huisartsenzorg: wat doet de poortwachter? Utrecht/Bilthoven: NIVEL/RIVM, 2004.
27.
go back to reference Van der Horst HE, Schellevis FG, Van Eijk JT, Bleijenberg G. Managing patients with irritable bowel syndrome in general practice. How to promote and reinforce self-care activities. Patient Educ Couns 1998;35:149-56. Van der Horst HE, Schellevis FG, Van Eijk JT, Bleijenberg G. Managing patients with irritable bowel syndrome in general practice. How to promote and reinforce self-care activities. Patient Educ Couns 1998;35:149-56.
28.
go back to reference Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005;331:435. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005;331:435.
29.
go back to reference Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4.
30.
go back to reference Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
Metagegevens
Titel
Prikkelbaredarmsyndroom in de huisartsenpraktijk
Auteur
René Bijkerk
Publicatiedatum
01-01-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Huisarts en wetenschap / Uitgave 1/2009
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912
DOI
https://doi.org/10.1007/BF03085490